Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria, Cerebral | 27 | 2022 | 136 | 5.640 |
Why?
|
Pathology | 10 | 2022 | 270 | 2.440 |
Why?
|
Plasmodium falciparum | 29 | 2023 | 1742 | 2.270 |
Why?
|
Malaria, Falciparum | 20 | 2023 | 1077 | 1.750 |
Why?
|
Laboratories | 6 | 2024 | 458 | 1.570 |
Why?
|
Pathology, Clinical | 3 | 2024 | 376 | 1.180 |
Why?
|
Malaria | 9 | 2021 | 1227 | 1.140 |
Why?
|
Capacity Building | 6 | 2021 | 258 | 1.050 |
Why?
|
Developing Countries | 11 | 2022 | 2885 | 0.940 |
Why?
|
Neoplasms | 21 | 2024 | 22170 | 0.930 |
Why?
|
Plasmodium | 3 | 2018 | 246 | 0.900 |
Why?
|
Malawi | 22 | 2018 | 304 | 0.880 |
Why?
|
Pathology, Molecular | 8 | 2022 | 328 | 0.800 |
Why?
|
Mycobacterium Infections | 3 | 2017 | 122 | 0.740 |
Why?
|
Parasitemia | 6 | 2015 | 165 | 0.660 |
Why?
|
Immunocompromised Host | 8 | 2015 | 856 | 0.650 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 746 | 0.560 |
Why?
|
Mycoses | 3 | 2014 | 386 | 0.510 |
Why?
|
Microsporidiosis | 1 | 2015 | 23 | 0.500 |
Why?
|
Altruism | 1 | 2017 | 208 | 0.500 |
Why?
|
Parasites | 2 | 2021 | 160 | 0.490 |
Why?
|
Communicable Diseases, Emerging | 1 | 2016 | 148 | 0.490 |
Why?
|
Virus Diseases | 2 | 2021 | 718 | 0.490 |
Why?
|
Spleen | 3 | 2016 | 2295 | 0.480 |
Why?
|
Statistics as Topic | 1 | 2021 | 2358 | 0.470 |
Why?
|
Accreditation | 1 | 2017 | 473 | 0.470 |
Why?
|
DNA, Protozoan | 3 | 2012 | 228 | 0.470 |
Why?
|
Biodiversity | 1 | 2016 | 347 | 0.450 |
Why?
|
Hematologic Diseases | 1 | 2017 | 496 | 0.440 |
Why?
|
Autopsy | 4 | 2022 | 1008 | 0.430 |
Why?
|
Histocytochemistry | 2 | 2014 | 698 | 0.430 |
Why?
|
Dermatofibrosarcoma | 1 | 2012 | 48 | 0.400 |
Why?
|
Frontal Lobe | 2 | 2012 | 1420 | 0.400 |
Why?
|
Erythrocytes | 13 | 2022 | 2413 | 0.400 |
Why?
|
Lung Diseases | 1 | 2022 | 1909 | 0.400 |
Why?
|
Histoplasma | 1 | 2011 | 39 | 0.390 |
Why?
|
Histoplasmosis | 1 | 2011 | 63 | 0.380 |
Why?
|
Africa | 6 | 2023 | 709 | 0.360 |
Why?
|
Humans | 141 | 2024 | 761504 | 0.350 |
Why?
|
Immunohistochemistry | 10 | 2022 | 11076 | 0.340 |
Why?
|
Communicable Diseases | 3 | 2017 | 875 | 0.330 |
Why?
|
Brain | 17 | 2022 | 27112 | 0.330 |
Why?
|
Adrenal Glands | 1 | 2011 | 552 | 0.320 |
Why?
|
Feces | 2 | 2015 | 1497 | 0.320 |
Why?
|
HIV Infections | 15 | 2024 | 17351 | 0.320 |
Why?
|
Medically Underserved Area | 2 | 2014 | 254 | 0.320 |
Why?
|
Organizations | 2 | 2021 | 171 | 0.320 |
Why?
|
Bacterial Infections | 1 | 2017 | 1390 | 0.310 |
Why?
|
Medical Oncology | 1 | 2020 | 2321 | 0.310 |
Why?
|
Rwanda | 9 | 2022 | 665 | 0.310 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2008 | 61 | 0.310 |
Why?
|
International Cooperation | 3 | 2020 | 1422 | 0.300 |
Why?
|
Antimalarials | 5 | 2023 | 907 | 0.290 |
Why?
|
Uveitis | 1 | 2011 | 395 | 0.290 |
Why?
|
Cities | 2 | 2021 | 546 | 0.290 |
Why?
|
Brain Diseases | 2 | 2018 | 1545 | 0.290 |
Why?
|
Plasmodium berghei | 3 | 2019 | 159 | 0.280 |
Why?
|
Protozoan Proteins | 6 | 2018 | 847 | 0.260 |
Why?
|
Child | 34 | 2022 | 80153 | 0.260 |
Why?
|
Gastrointestinal Diseases | 1 | 2014 | 1200 | 0.250 |
Why?
|
Brain Edema | 2 | 2022 | 604 | 0.230 |
Why?
|
Child, Preschool | 24 | 2021 | 42230 | 0.230 |
Why?
|
Fusobacterium nucleatum | 2 | 2015 | 179 | 0.230 |
Why?
|
Cooperative Behavior | 2 | 2017 | 1505 | 0.230 |
Why?
|
Fever | 1 | 2011 | 1618 | 0.220 |
Why?
|
Lung | 4 | 2022 | 10000 | 0.210 |
Why?
|
Antigens, Protozoan | 3 | 2017 | 316 | 0.210 |
Why?
|
Life Cycle Stages | 2 | 2014 | 160 | 0.210 |
Why?
|
Bone Marrow | 3 | 2018 | 2911 | 0.210 |
Why?
|
Quality Improvement | 1 | 2017 | 3801 | 0.200 |
Why?
|
Paraguay | 1 | 2021 | 7 | 0.190 |
Why?
|
Myanmar | 1 | 2021 | 44 | 0.190 |
Why?
|
Gene Expression Profiling | 3 | 2017 | 9420 | 0.190 |
Why?
|
Genome, Protozoan | 2 | 2016 | 152 | 0.190 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2015 | 343 | 0.190 |
Why?
|
Antigens, CD | 4 | 2017 | 4003 | 0.190 |
Why?
|
Pneumonia, Bacterial | 2 | 2021 | 316 | 0.180 |
Why?
|
Biopsy, Needle | 3 | 2012 | 1626 | 0.180 |
Why?
|
Biopsy | 6 | 2022 | 6766 | 0.180 |
Why?
|
Brain Abscess | 2 | 2012 | 120 | 0.180 |
Why?
|
Health Services Needs and Demand | 2 | 2019 | 1403 | 0.180 |
Why?
|
Telepathology | 2 | 2018 | 77 | 0.180 |
Why?
|
Haiti | 3 | 2017 | 550 | 0.180 |
Why?
|
Colombia | 1 | 2021 | 282 | 0.180 |
Why?
|
RNA, Viral | 6 | 2021 | 2846 | 0.170 |
Why?
|
Epidemiology | 2 | 2012 | 279 | 0.170 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2017 | 611 | 0.170 |
Why?
|
Models, Educational | 2 | 2012 | 373 | 0.170 |
Why?
|
Partnership Practice | 1 | 2019 | 14 | 0.170 |
Why?
|
Public Health | 4 | 2020 | 2669 | 0.170 |
Why?
|
World Health Organization | 3 | 2020 | 1322 | 0.170 |
Why?
|
Retinal Diseases | 2 | 2018 | 705 | 0.160 |
Why?
|
Atherosclerosis | 1 | 2015 | 3408 | 0.160 |
Why?
|
Candidiasis | 2 | 2011 | 365 | 0.160 |
Why?
|
Regional Health Planning | 1 | 2019 | 96 | 0.160 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 11903 | 0.160 |
Why?
|
Gastrointestinal Tract | 2 | 2015 | 833 | 0.160 |
Why?
|
Candida albicans | 2 | 2011 | 372 | 0.160 |
Why?
|
Macrophages | 1 | 2013 | 5769 | 0.150 |
Why?
|
Genetic Variation | 6 | 2016 | 6567 | 0.150 |
Why?
|
Plasmodium vivax | 2 | 2018 | 202 | 0.150 |
Why?
|
Laboratory Proficiency Testing | 1 | 2017 | 20 | 0.150 |
Why?
|
Africa South of the Sahara | 2 | 2019 | 744 | 0.150 |
Why?
|
Lectins, C-Type | 2 | 2011 | 585 | 0.150 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13380 | 0.150 |
Why?
|
Molecular Epidemiology | 2 | 2018 | 469 | 0.150 |
Why?
|
Polymerase Chain Reaction | 5 | 2016 | 6075 | 0.150 |
Why?
|
Placenta | 4 | 2018 | 1709 | 0.150 |
Why?
|
Penile Neoplasms | 1 | 2019 | 161 | 0.150 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2018 | 100 | 0.150 |
Why?
|
Infant | 16 | 2018 | 36192 | 0.140 |
Why?
|
Female | 50 | 2023 | 392644 | 0.140 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2019 | 219 | 0.140 |
Why?
|
Receptors, Immunologic | 3 | 2012 | 1410 | 0.140 |
Why?
|
Male | 48 | 2023 | 360804 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2012 | 1351 | 0.140 |
Why?
|
Tropical Medicine | 1 | 2017 | 51 | 0.140 |
Why?
|
Vietnam | 1 | 2017 | 409 | 0.140 |
Why?
|
Microscopy | 1 | 2022 | 903 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2023 | 1298 | 0.140 |
Why?
|
Macula Lutea | 1 | 2018 | 177 | 0.140 |
Why?
|
Interdisciplinary Communication | 2 | 2012 | 931 | 0.140 |
Why?
|
Government Programs | 1 | 2018 | 279 | 0.130 |
Why?
|
Internationality | 1 | 2022 | 1001 | 0.130 |
Why?
|
Malaria Vaccines | 1 | 2017 | 165 | 0.130 |
Why?
|
Babesia microti | 1 | 2016 | 31 | 0.130 |
Why?
|
Health Priorities | 1 | 2019 | 374 | 0.130 |
Why?
|
Malaria, Vivax | 1 | 2018 | 166 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2021 | 1078 | 0.130 |
Why?
|
Bacillus cereus | 1 | 2015 | 36 | 0.130 |
Why?
|
Capillaries | 2 | 2022 | 755 | 0.130 |
Why?
|
Microsporidia | 1 | 2015 | 6 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1374 | 0.130 |
Why?
|
Tamoxifen | 1 | 2020 | 965 | 0.130 |
Why?
|
Fusarium | 1 | 2015 | 51 | 0.130 |
Why?
|
Health Personnel | 3 | 2018 | 3335 | 0.130 |
Why?
|
Anus Neoplasms | 1 | 2019 | 329 | 0.130 |
Why?
|
Tissue Array Analysis | 2 | 2015 | 550 | 0.120 |
Why?
|
Conservation of Natural Resources | 1 | 2017 | 211 | 0.120 |
Why?
|
Pneumonia | 3 | 2017 | 2143 | 0.120 |
Why?
|
Babesiosis | 1 | 2016 | 92 | 0.120 |
Why?
|
Biostatistics | 1 | 2016 | 164 | 0.120 |
Why?
|
Nigeria | 3 | 2015 | 770 | 0.120 |
Why?
|
Meningoencephalitis | 1 | 2015 | 83 | 0.120 |
Why?
|
Breast Neoplasms | 5 | 2023 | 21012 | 0.120 |
Why?
|
Measles virus | 1 | 2015 | 67 | 0.120 |
Why?
|
Biomedical Research | 3 | 2020 | 3429 | 0.120 |
Why?
|
HIV-1 | 8 | 2017 | 6863 | 0.120 |
Why?
|
Lassa virus | 1 | 2015 | 99 | 0.120 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2023 | 2020 | 0.120 |
Why?
|
United States | 12 | 2021 | 72334 | 0.120 |
Why?
|
Urogenital System | 1 | 2014 | 88 | 0.120 |
Why?
|
Lassa Fever | 1 | 2015 | 97 | 0.120 |
Why?
|
Endocrine Glands | 1 | 2014 | 102 | 0.120 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2014 | 76 | 0.120 |
Why?
|
Virulence Factors | 1 | 2018 | 513 | 0.110 |
Why?
|
Thrombin | 1 | 2016 | 591 | 0.110 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 532 | 0.110 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2013 | 2151 | 0.110 |
Why?
|
Pulmonary Aspergillosis | 1 | 2014 | 47 | 0.110 |
Why?
|
Opportunistic Infections | 2 | 2014 | 376 | 0.110 |
Why?
|
Carcinoma | 2 | 2015 | 2330 | 0.110 |
Why?
|
Melioidosis | 1 | 2013 | 11 | 0.110 |
Why?
|
Peritonitis, Tuberculous | 1 | 2013 | 6 | 0.110 |
Why?
|
Species Specificity | 1 | 2018 | 2414 | 0.110 |
Why?
|
Genotype | 9 | 2019 | 12990 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2017 | 1606 | 0.110 |
Why?
|
Epigenomics | 2 | 2016 | 943 | 0.110 |
Why?
|
Host-Pathogen Interactions | 3 | 2016 | 1459 | 0.110 |
Why?
|
Hepatitis C | 1 | 2023 | 1584 | 0.110 |
Why?
|
Income | 1 | 2022 | 1877 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1119 | 0.110 |
Why?
|
Drug Resistance | 2 | 2011 | 1596 | 0.110 |
Why?
|
Skin | 4 | 2015 | 4484 | 0.110 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5821 | 0.100 |
Why?
|
Adenoviruses, Human | 1 | 2014 | 255 | 0.100 |
Why?
|
Measles | 1 | 2015 | 183 | 0.100 |
Why?
|
Cytochromes b | 2 | 2016 | 35 | 0.100 |
Why?
|
Disease Models, Animal | 5 | 2018 | 18252 | 0.100 |
Why?
|
Trophozoites | 1 | 2012 | 12 | 0.100 |
Why?
|
Urban Population | 2 | 2019 | 2036 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1901 | 0.100 |
Why?
|
Schizonts | 1 | 2012 | 22 | 0.100 |
Why?
|
Granuloma | 1 | 2014 | 328 | 0.100 |
Why?
|
Encephalitis, Viral | 1 | 2012 | 58 | 0.100 |
Why?
|
Retinal Vessels | 1 | 2018 | 852 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 4580 | 0.100 |
Why?
|
Fetal Proteins | 1 | 2012 | 98 | 0.100 |
Why?
|
Diagnosis-Related Groups | 1 | 2013 | 449 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2011 | 91 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 787 | 0.100 |
Why?
|
Arthritis, Infectious | 1 | 2015 | 347 | 0.100 |
Why?
|
HIV-2 | 1 | 2012 | 156 | 0.100 |
Why?
|
Histological Techniques | 1 | 2012 | 193 | 0.100 |
Why?
|
Mycology | 1 | 2011 | 13 | 0.100 |
Why?
|
Animals | 27 | 2021 | 168459 | 0.100 |
Why?
|
Genome, Viral | 1 | 2015 | 667 | 0.100 |
Why?
|
Molecular Typing | 1 | 2012 | 116 | 0.100 |
Why?
|
Colorectal Neoplasms | 3 | 2015 | 6935 | 0.090 |
Why?
|
Selection, Genetic | 3 | 2013 | 868 | 0.090 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3204 | 0.090 |
Why?
|
Climate Change | 1 | 2017 | 501 | 0.090 |
Why?
|
Mucorales | 1 | 2011 | 35 | 0.090 |
Why?
|
Immunity, Mucosal | 1 | 2014 | 483 | 0.090 |
Why?
|
Macrophage-1 Antigen | 1 | 2011 | 285 | 0.090 |
Why?
|
Host-Parasite Interactions | 2 | 2018 | 300 | 0.090 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5440 | 0.090 |
Why?
|
Eligibility Determination | 1 | 2014 | 421 | 0.090 |
Why?
|
Rural Health Services | 1 | 2014 | 384 | 0.090 |
Why?
|
Pathology, Surgical | 1 | 2012 | 151 | 0.090 |
Why?
|
Micrococcaceae | 1 | 2010 | 8 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2495 | 0.090 |
Why?
|
Lymphadenitis | 1 | 2011 | 99 | 0.090 |
Why?
|
Ascomycota | 1 | 2011 | 81 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2015 | 726 | 0.090 |
Why?
|
Geotrichosis | 1 | 2009 | 2 | 0.090 |
Why?
|
Geotrichum | 1 | 2009 | 4 | 0.090 |
Why?
|
Genetics, Population | 1 | 2015 | 937 | 0.090 |
Why?
|
Cytomegalovirus | 1 | 2014 | 756 | 0.090 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2015 | 3613 | 0.090 |
Why?
|
Cytological Techniques | 1 | 2012 | 218 | 0.090 |
Why?
|
Incidence | 3 | 2019 | 21353 | 0.090 |
Why?
|
Mucormycosis | 1 | 2011 | 103 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2022 | 12795 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2012 | 15936 | 0.090 |
Why?
|
Cell Adhesion | 1 | 2016 | 3087 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1463 | 0.080 |
Why?
|
Chemokines | 2 | 2012 | 960 | 0.080 |
Why?
|
Schools | 1 | 2018 | 1489 | 0.080 |
Why?
|
Staining and Labeling | 1 | 2014 | 1085 | 0.080 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14666 | 0.080 |
Why?
|
Scalp | 1 | 2012 | 389 | 0.080 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1092 | 0.080 |
Why?
|
Fetal Blood | 2 | 2014 | 1347 | 0.080 |
Why?
|
Blood | 1 | 2012 | 596 | 0.080 |
Why?
|
Nutritional Status | 1 | 2017 | 1615 | 0.080 |
Why?
|
Transplantation | 1 | 2011 | 219 | 0.080 |
Why?
|
Abscess | 2 | 2013 | 606 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2022 | 3357 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 2012 | 910 | 0.080 |
Why?
|
Eye Diseases | 1 | 2014 | 653 | 0.080 |
Why?
|
Anti-HIV Agents | 3 | 2014 | 4527 | 0.080 |
Why?
|
Myasthenia Gravis | 1 | 2011 | 214 | 0.080 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2373 | 0.080 |
Why?
|
Retina | 2 | 2022 | 2659 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2017 | 1203 | 0.080 |
Why?
|
DNA Fingerprinting | 1 | 2008 | 114 | 0.080 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1117 | 0.080 |
Why?
|
Middle Aged | 21 | 2021 | 220895 | 0.080 |
Why?
|
Rural Health | 1 | 2010 | 296 | 0.080 |
Why?
|
Vaccines | 1 | 2017 | 844 | 0.080 |
Why?
|
Dermatitis | 1 | 2010 | 202 | 0.080 |
Why?
|
AIDS Vaccines | 1 | 2014 | 896 | 0.070 |
Why?
|
Skin Diseases, Bacterial | 1 | 2008 | 68 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2014 | 831 | 0.070 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 1738 | 0.070 |
Why?
|
Treponema pallidum | 2 | 2023 | 47 | 0.070 |
Why?
|
Blood Vessels | 1 | 2013 | 1113 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3201 | 0.070 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1613 | 0.070 |
Why?
|
Research Design | 2 | 2021 | 6180 | 0.070 |
Why?
|
Pregnancy | 7 | 2018 | 29874 | 0.070 |
Why?
|
Encephalitis | 1 | 2011 | 438 | 0.070 |
Why?
|
Blood Coagulation | 1 | 2013 | 1154 | 0.070 |
Why?
|
Proguanil | 1 | 2006 | 11 | 0.070 |
Why?
|
Diagnosis, Differential | 4 | 2016 | 12974 | 0.070 |
Why?
|
Receptors, Cell Surface | 2 | 2013 | 2822 | 0.070 |
Why?
|
Adult | 19 | 2021 | 221177 | 0.070 |
Why?
|
History, 21st Century | 1 | 2013 | 1567 | 0.070 |
Why?
|
Naphthoquinones | 1 | 2006 | 58 | 0.070 |
Why?
|
Tumor Burden | 1 | 2012 | 1893 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3743 | 0.070 |
Why?
|
Cross Infection | 1 | 2015 | 1422 | 0.070 |
Why?
|
Face | 1 | 2012 | 1026 | 0.070 |
Why?
|
Senegal | 3 | 2015 | 256 | 0.070 |
Why?
|
Cadherins | 1 | 2011 | 903 | 0.070 |
Why?
|
Monocytes | 1 | 2015 | 2570 | 0.070 |
Why?
|
Disease Transmission, Infectious | 1 | 2011 | 559 | 0.070 |
Why?
|
Microarray Analysis | 1 | 2008 | 749 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7390 | 0.060 |
Why?
|
Strongyloides stercoralis | 1 | 2005 | 23 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 4 | 2014 | 2571 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2012 | 1742 | 0.060 |
Why?
|
Strongyloidiasis | 1 | 2005 | 27 | 0.060 |
Why?
|
Antiparasitic Agents | 1 | 2005 | 42 | 0.060 |
Why?
|
Ivermectin | 1 | 2005 | 46 | 0.060 |
Why?
|
Case-Control Studies | 5 | 2015 | 22176 | 0.060 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2006 | 411 | 0.060 |
Why?
|
Communicable Disease Control | 1 | 2011 | 846 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20098 | 0.060 |
Why?
|
Zoonoses | 2 | 2016 | 179 | 0.060 |
Why?
|
History, 20th Century | 1 | 2013 | 2767 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2012 | 2707 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1651 | 0.060 |
Why?
|
Blood Platelets | 1 | 2015 | 2479 | 0.060 |
Why?
|
Community Health Services | 1 | 2010 | 656 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3600 | 0.060 |
Why?
|
Blood-Brain Barrier | 1 | 2011 | 1027 | 0.060 |
Why?
|
Fatigue | 1 | 2011 | 1552 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3595 | 0.060 |
Why?
|
Leishmaniasis, Mucocutaneous | 1 | 2003 | 14 | 0.060 |
Why?
|
Prevalence | 3 | 2019 | 15732 | 0.060 |
Why?
|
Viral Load | 5 | 2012 | 3332 | 0.060 |
Why?
|
Gingival Diseases | 1 | 2003 | 36 | 0.060 |
Why?
|
Syphilis | 1 | 2006 | 243 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15842 | 0.060 |
Why?
|
Gene Expression | 2 | 2013 | 7581 | 0.060 |
Why?
|
Africa, Western | 2 | 2015 | 159 | 0.060 |
Why?
|
Drugs, Essential | 1 | 2024 | 72 | 0.050 |
Why?
|
Internship and Residency | 3 | 2020 | 5880 | 0.050 |
Why?
|
Adolescent | 11 | 2021 | 88319 | 0.050 |
Why?
|
Palate | 1 | 2003 | 124 | 0.050 |
Why?
|
Zambia | 1 | 2024 | 262 | 0.050 |
Why?
|
Bacteremia | 1 | 2010 | 979 | 0.050 |
Why?
|
Risk | 1 | 2015 | 9610 | 0.050 |
Why?
|
Oral Ulcer | 1 | 2003 | 96 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2018 | 4330 | 0.050 |
Why?
|
Blood Banks | 1 | 2023 | 108 | 0.050 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2004 | 169 | 0.050 |
Why?
|
Shock, Septic | 1 | 2009 | 768 | 0.050 |
Why?
|
Alkaline Phosphatase | 1 | 2005 | 864 | 0.050 |
Why?
|
Glucosamine | 1 | 2022 | 128 | 0.050 |
Why?
|
Atovaquone | 2 | 2016 | 56 | 0.050 |
Why?
|
Mannose | 1 | 2022 | 121 | 0.050 |
Why?
|
Coma | 1 | 2006 | 484 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3424 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3877 | 0.050 |
Why?
|
Cytokines | 3 | 2014 | 7396 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4652 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2017 | 5336 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2021 | 80636 | 0.050 |
Why?
|
Blood-Retinal Barrier | 1 | 2022 | 62 | 0.050 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2022 | 174 | 0.050 |
Why?
|
Microsatellite Instability | 2 | 2015 | 716 | 0.050 |
Why?
|
Ligases | 1 | 2023 | 333 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2632 | 0.050 |
Why?
|
Lymphocyte Count | 2 | 2015 | 778 | 0.050 |
Why?
|
Glycocalyx | 1 | 2022 | 97 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4726 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2015 | 11121 | 0.050 |
Why?
|
Antifungal Agents | 3 | 2011 | 752 | 0.050 |
Why?
|
Blood Donors | 1 | 2023 | 345 | 0.050 |
Why?
|
Trans-Activators | 1 | 2011 | 2856 | 0.050 |
Why?
|
Point Mutation | 1 | 2006 | 1595 | 0.050 |
Why?
|
Aged | 9 | 2015 | 169289 | 0.050 |
Why?
|
Inflammation | 2 | 2013 | 10773 | 0.050 |
Why?
|
Mozambique | 1 | 2021 | 55 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2013 | 4431 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1600 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2009 | 4806 | 0.050 |
Why?
|
Mice | 7 | 2021 | 81525 | 0.050 |
Why?
|
Gene Amplification | 1 | 2005 | 1089 | 0.050 |
Why?
|
Sierra Leone | 1 | 2021 | 169 | 0.050 |
Why?
|
Lectins | 1 | 2022 | 491 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3810 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11118 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 59243 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2009 | 1880 | 0.040 |
Why?
|
Technology | 1 | 2022 | 292 | 0.040 |
Why?
|
Weight Loss | 1 | 2011 | 2684 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2017 | 2469 | 0.040 |
Why?
|
Women's Health Services | 1 | 2020 | 88 | 0.040 |
Why?
|
Genomics | 3 | 2016 | 5821 | 0.040 |
Why?
|
Exanthema | 1 | 2004 | 503 | 0.040 |
Why?
|
Glycosaminoglycans | 1 | 2022 | 607 | 0.040 |
Why?
|
Antibodies, Protozoan | 2 | 2011 | 252 | 0.040 |
Why?
|
Oncogenes | 1 | 2005 | 1222 | 0.040 |
Why?
|
Glioblastoma | 1 | 2014 | 3482 | 0.040 |
Why?
|
Tanzania | 1 | 2023 | 1387 | 0.040 |
Why?
|
Neutrophils | 1 | 2011 | 3767 | 0.040 |
Why?
|
Prospective Studies | 4 | 2022 | 54425 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2022 | 1126 | 0.040 |
Why?
|
Medical Audit | 2 | 2013 | 453 | 0.040 |
Why?
|
Vaginal Neoplasms | 1 | 2019 | 104 | 0.040 |
Why?
|
Mononuclear Phagocyte System | 1 | 2018 | 54 | 0.040 |
Why?
|
Aotidae | 1 | 2018 | 59 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4615 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2014 | 64680 | 0.040 |
Why?
|
Diagnosis | 1 | 2019 | 157 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2012 | 3080 | 0.040 |
Why?
|
Food Chain | 1 | 2017 | 27 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2011 | 2491 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10194 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5840 | 0.040 |
Why?
|
Madagascar | 1 | 2017 | 110 | 0.040 |
Why?
|
South Africa | 1 | 2023 | 1842 | 0.040 |
Why?
|
Premature Birth | 2 | 2013 | 1782 | 0.040 |
Why?
|
Chordata, Nonvertebrate | 1 | 1997 | 14 | 0.040 |
Why?
|
Butyrylcholinesterase | 1 | 1997 | 21 | 0.040 |
Why?
|
Saimiri | 1 | 2018 | 334 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5796 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2006 | 2571 | 0.040 |
Why?
|
Developed Countries | 1 | 2020 | 449 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2011 | 3233 | 0.040 |
Why?
|
Financial Management | 1 | 2018 | 160 | 0.040 |
Why?
|
Acetylcholinesterase | 1 | 1997 | 156 | 0.030 |
Why?
|
Vulvar Neoplasms | 1 | 2019 | 263 | 0.030 |
Why?
|
DNA, Bacterial | 2 | 2015 | 1479 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 36426 | 0.030 |
Why?
|
Infant, Newborn | 5 | 2017 | 26198 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4174 | 0.030 |
Why?
|
Standard of Care | 1 | 2020 | 551 | 0.030 |
Why?
|
Allergy and Immunology | 1 | 2018 | 176 | 0.030 |
Why?
|
Cell Lineage | 1 | 2005 | 2555 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2503 | 0.030 |
Why?
|
Receptors, Interleukin-10 | 1 | 2016 | 50 | 0.030 |
Why?
|
Murinae | 1 | 2015 | 18 | 0.030 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
Problem Solving | 1 | 2018 | 441 | 0.030 |
Why?
|
Observer Variation | 1 | 2022 | 2606 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1522 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2016 | 145 | 0.030 |
Why?
|
Faculty | 1 | 2018 | 384 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 2015 | 121 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2017 | 695 | 0.030 |
Why?
|
Azithromycin | 1 | 2016 | 199 | 0.030 |
Why?
|
Haptoglobins | 1 | 2016 | 166 | 0.030 |
Why?
|
Virology | 1 | 2015 | 75 | 0.030 |
Why?
|
Colon | 2 | 2014 | 1792 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39106 | 0.030 |
Why?
|
Measles Vaccine | 1 | 2015 | 80 | 0.030 |
Why?
|
Suicide | 1 | 2005 | 1601 | 0.030 |
Why?
|
Viral Tropism | 1 | 2015 | 102 | 0.030 |
Why?
|
Rosaniline Dyes | 1 | 2014 | 50 | 0.030 |
Why?
|
Hematopoietic System | 1 | 2014 | 110 | 0.030 |
Why?
|
Cause of Death | 1 | 2005 | 3683 | 0.030 |
Why?
|
Ganciclovir | 1 | 2014 | 252 | 0.030 |
Why?
|
Peer Review, Research | 1 | 2017 | 340 | 0.030 |
Why?
|
Gene Dosage | 2 | 2011 | 1217 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2016 | 371 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2016 | 344 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15266 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 12947 | 0.030 |
Why?
|
Thienamycins | 1 | 2013 | 29 | 0.030 |
Why?
|
Burkholderia pseudomallei | 1 | 2013 | 9 | 0.030 |
Why?
|
Papilledema | 1 | 2015 | 130 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 793 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2017 | 4369 | 0.030 |
Why?
|
Proteomics | 2 | 2017 | 3849 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2014 | 9031 | 0.030 |
Why?
|
Phylogeny | 3 | 2008 | 2811 | 0.030 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2014 | 173 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2014 | 554 | 0.030 |
Why?
|
Mutation | 4 | 2023 | 30052 | 0.030 |
Why?
|
Genes | 1 | 1997 | 1823 | 0.030 |
Why?
|
Cambodia | 1 | 2013 | 185 | 0.030 |
Why?
|
Leptin | 1 | 2021 | 1597 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2017 | 697 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2015 | 58976 | 0.030 |
Why?
|
Thrombomodulin | 1 | 2013 | 105 | 0.030 |
Why?
|
Ebolavirus | 1 | 2015 | 251 | 0.030 |
Why?
|
Gadolinium | 1 | 2018 | 960 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1787 | 0.030 |
Why?
|
Angiography | 1 | 2018 | 1595 | 0.030 |
Why?
|
Lactic Acid | 1 | 2018 | 1139 | 0.030 |
Why?
|
Esophageal Neoplasms | 2 | 2013 | 1654 | 0.030 |
Why?
|
Immunoassay | 1 | 2016 | 745 | 0.030 |
Why?
|
Signal Transduction | 2 | 2012 | 23445 | 0.020 |
Why?
|
Propionibacterium acnes | 1 | 2012 | 65 | 0.020 |
Why?
|
Omentum | 1 | 2013 | 168 | 0.020 |
Why?
|
Plasmodium knowlesi | 1 | 2012 | 23 | 0.020 |
Why?
|
Duffy Blood-Group System | 1 | 2012 | 58 | 0.020 |
Why?
|
Schistosomiasis | 1 | 2012 | 65 | 0.020 |
Why?
|
Radiography | 2 | 2014 | 6965 | 0.020 |
Why?
|
Reye Syndrome | 1 | 2011 | 28 | 0.020 |
Why?
|
Mefloquine | 1 | 2011 | 55 | 0.020 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 369 | 0.020 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2011 | 57 | 0.020 |
Why?
|
Health Education | 1 | 2018 | 1052 | 0.020 |
Why?
|
Comprehension | 1 | 2016 | 621 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2018 | 815 | 0.020 |
Why?
|
Cohort Studies | 4 | 2017 | 41487 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 26125 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 899 | 0.020 |
Why?
|
Phenanthrenes | 1 | 2011 | 66 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2012 | 5869 | 0.020 |
Why?
|
Virulence | 1 | 2015 | 1303 | 0.020 |
Why?
|
Risk Assessment | 1 | 2012 | 23995 | 0.020 |
Why?
|
Fluconazole | 1 | 2011 | 157 | 0.020 |
Why?
|
Ethanolamines | 1 | 2011 | 153 | 0.020 |
Why?
|
Recurrence | 2 | 2016 | 8465 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 9000 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2012 | 445 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15500 | 0.020 |
Why?
|
Foreign Bodies | 1 | 1994 | 402 | 0.020 |
Why?
|
Ritonavir | 1 | 2012 | 329 | 0.020 |
Why?
|
Actinomycetales Infections | 1 | 2010 | 30 | 0.020 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 420 | 0.020 |
Why?
|
Hospitals | 1 | 2024 | 3882 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2013 | 2223 | 0.020 |
Why?
|
DNA, Ribosomal | 1 | 2011 | 300 | 0.020 |
Why?
|
Fluorenes | 1 | 2011 | 157 | 0.020 |
Why?
|
DNA, Fungal | 1 | 2011 | 275 | 0.020 |
Why?
|
Publishing | 1 | 2017 | 833 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2928 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1834 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1071 | 0.020 |
Why?
|
Anopheles | 1 | 2011 | 192 | 0.020 |
Why?
|
Live Birth | 1 | 2013 | 511 | 0.020 |
Why?
|
Primates | 1 | 2012 | 523 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2018 | 1213 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3312 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2017 | 1897 | 0.020 |
Why?
|
Suppuration | 1 | 2008 | 60 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 2014 | 684 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2020 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 2011 | 825 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6216 | 0.020 |
Why?
|
Skull | 1 | 2013 | 818 | 0.020 |
Why?
|
Esophagus | 1 | 1994 | 1033 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1589 | 0.020 |
Why?
|
Students | 1 | 2018 | 1741 | 0.020 |
Why?
|
Health Resources | 1 | 2014 | 935 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2006 | 2748 | 0.020 |
Why?
|
National Health Programs | 1 | 2011 | 440 | 0.020 |
Why?
|
Cervix Uteri | 1 | 2012 | 570 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1804 | 0.020 |
Why?
|
Cell Membrane | 1 | 2017 | 3688 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9606 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 1039 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2012 | 877 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2203 | 0.020 |
Why?
|
Proteome | 1 | 2017 | 1862 | 0.020 |
Why?
|
HIV Antibodies | 1 | 2014 | 1303 | 0.020 |
Why?
|
Geography | 1 | 2009 | 656 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1745 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29625 | 0.020 |
Why?
|
Chronic Disease | 2 | 2012 | 9318 | 0.020 |
Why?
|
Central America | 1 | 2006 | 69 | 0.020 |
Why?
|
Multiple Birth Offspring | 1 | 2006 | 22 | 0.020 |
Why?
|
Drug Therapy | 1 | 2010 | 503 | 0.020 |
Why?
|
Time Factors | 3 | 2021 | 39967 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 803 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1659 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2819 | 0.020 |
Why?
|
South America | 1 | 2006 | 179 | 0.020 |
Why?
|
Melanoma | 1 | 2005 | 5709 | 0.020 |
Why?
|
Adenine | 1 | 2012 | 987 | 0.020 |
Why?
|
Merozoite Surface Protein 1 | 1 | 2006 | 38 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2012 | 791 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7827 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22169 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 2048 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 1998 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2865 | 0.020 |
Why?
|
Phagocytosis | 1 | 2011 | 1528 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2919 | 0.020 |
Why?
|
Anemia | 2 | 2006 | 1509 | 0.020 |
Why?
|
Risk Factors | 3 | 2015 | 74206 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2011 | 1560 | 0.020 |
Why?
|
Seasons | 1 | 2011 | 1520 | 0.020 |
Why?
|
Transcription Factors | 1 | 2005 | 12128 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2057 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2006 | 767 | 0.020 |
Why?
|
Veterinary Medicine | 1 | 2005 | 21 | 0.020 |
Why?
|
Triazoles | 1 | 2011 | 903 | 0.020 |
Why?
|
Age Factors | 2 | 2014 | 18395 | 0.020 |
Why?
|
Forensic Medicine | 1 | 2005 | 64 | 0.020 |
Why?
|
Methods | 1 | 2005 | 1067 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1720 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3778 | 0.020 |
Why?
|
Asia | 1 | 2006 | 619 | 0.020 |
Why?
|
Models, Genetic | 1 | 2015 | 3442 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6484 | 0.010 |
Why?
|
Tuberculosis | 1 | 2017 | 2017 | 0.010 |
Why?
|
Seizures | 1 | 2018 | 2957 | 0.010 |
Why?
|
Haplotypes | 1 | 2011 | 2713 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1600 | 0.010 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2008 | 547 | 0.010 |
Why?
|
Codon | 1 | 2006 | 601 | 0.010 |
Why?
|
Sequence Analysis, DNA | 2 | 2011 | 4740 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 527 | 0.010 |
Why?
|
Child Mortality | 1 | 2007 | 205 | 0.010 |
Why?
|
Antitubercular Agents | 1 | 2013 | 1375 | 0.010 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2005 | 322 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2220 | 0.010 |
Why?
|
Antimony Sodium Gluconate | 1 | 2003 | 10 | 0.010 |
Why?
|
Neck Injuries | 1 | 2005 | 160 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
Diabetes Insipidus | 1 | 2004 | 144 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9351 | 0.010 |
Why?
|
Prednisone | 1 | 2008 | 1563 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3639 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2005 | 681 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2016 | 3548 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3032 | 0.010 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2005 | 259 | 0.010 |
Why?
|
Antiprotozoal Agents | 1 | 2003 | 94 | 0.010 |
Why?
|
Chorioamnionitis | 1 | 2004 | 156 | 0.010 |
Why?
|
Blood Glucose | 1 | 2018 | 6391 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9646 | 0.010 |
Why?
|
Virus Replication | 1 | 2011 | 2435 | 0.010 |
Why?
|
Liver | 2 | 2011 | 7529 | 0.010 |
Why?
|
Pesticides | 1 | 2005 | 296 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10090 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3589 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2006 | 2180 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2014 | 3060 | 0.010 |
Why?
|
Disease Progression | 2 | 2012 | 13506 | 0.010 |
Why?
|
Duodenum | 1 | 2005 | 490 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12059 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6310 | 0.010 |
Why?
|
Gene Frequency | 1 | 2008 | 3606 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2735 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 2006 | 870 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13639 | 0.010 |
Why?
|
DNA Methylation | 1 | 2015 | 4398 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 13446 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18965 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13255 | 0.010 |
Why?
|
Travel | 1 | 2006 | 796 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2281 | 0.010 |
Why?
|
Health Promotion | 1 | 2012 | 2214 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2011 | 5486 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7967 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2880 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 17635 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5972 | 0.010 |
Why?
|
Wounds, Gunshot | 1 | 2005 | 582 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2005 | 2510 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 1809 | 0.010 |
Why?
|
Pyrimidines | 1 | 2011 | 3028 | 0.010 |
Why?
|
Delivery, Obstetric | 1 | 2005 | 940 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2009 | 4544 | 0.010 |
Why?
|
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide | 1 | 1997 | 1 | 0.010 |
Why?
|
Tetraisopropylpyrophosphamide | 1 | 1997 | 2 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4320 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16591 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9469 | 0.010 |
Why?
|
Physostigmine | 1 | 1997 | 50 | 0.010 |
Why?
|
Intestines | 1 | 2006 | 1909 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4026 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14414 | 0.010 |
Why?
|
Mothers | 1 | 2006 | 2198 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2006 | 2921 | 0.010 |
Why?
|
Cell Survival | 1 | 2005 | 5791 | 0.010 |
Why?
|
Cholinesterase Inhibitors | 1 | 1997 | 242 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7407 | 0.010 |
Why?
|
Esophagoscopy | 1 | 1994 | 396 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12725 | 0.010 |
Why?
|
Surgical Instruments | 1 | 1994 | 383 | 0.010 |
Why?
|
Mucous Membrane | 1 | 1994 | 659 | 0.010 |
Why?
|
Kidney | 1 | 2006 | 7048 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5777 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2008 | 12690 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2005 | 8547 | 0.010 |
Why?
|
Kinetics | 1 | 1997 | 6374 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16981 | 0.000 |
Why?
|
Binding Sites | 1 | 1997 | 6055 | 0.000 |
Why?
|
Base Sequence | 1 | 1997 | 12441 | 0.000 |
Why?
|
Acute Disease | 1 | 1994 | 7237 | 0.000 |
Why?
|